27 related articles for article (PubMed ID: 9625258)
21. Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo.
White SJ; Page SM; Margaritis P; Brownlee GG
Hum Gene Ther; 1998 May; 9(8):1187-95. PubMed ID: 9625258
[TBL] [Abstract][Full Text] [Related]
22. Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.
Baum C; Eckert HG; Stockschläder M; Just U; Hegewisch-Becker S; Hildinger M; Uhde A; John J; Ostertag W
J Hematother; 1996 Aug; 5(4):323-9. PubMed ID: 8877707
[TBL] [Abstract][Full Text] [Related]
23. High-level secretion of growth hormone by retrovirally transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy.
Peroni CN; Cecchi CR; Damiani R; Soares CR; Ribela MT; do Rocio Arkaten R; Bartolini P
Mol Biotechnol; 2006 Oct; 34(2):239-45. PubMed ID: 17172669
[TBL] [Abstract][Full Text] [Related]
24. Skin genetically engineered as a bioreactor or a 'metabolic sink'.
Christensen R; Jensen UB; Jensen TG
Cells Tissues Organs; 2002; 172(2):96-104. PubMed ID: 12426486
[TBL] [Abstract][Full Text] [Related]
25. [Cutaneous gene therapy--perspectives of gene transfer in keratinocytes].
Braun-Falco M; Hallek M
Hautarzt; 1998 Jul; 49(7):536-44. PubMed ID: 9715380
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
